Abstract

Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2011 - Volume 15, Number 4

Page(s): 342

Download in electronic PDF format for $75
  • Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension Page 1

Abstract

A formulation for preparing Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • quetiapine fumarate
  • antipsychotic agent
  • formulation
  • schizophrenia
  • psychotic disorders
  • bipolar disorder

Related Categories

  • FORMULATIONS
  • MENTAL HEALTH

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2011
Pg. 342
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 506
Quetiapine Fumarate 10 mg/mL in Ora-Blend
Author(s): Allen Loyd V Jr
Sep/Oct 2024
Pg. 396
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Jul/Aug 2011
Pg. 340
Methylprednisolone 4-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jul/Aug 2019
Pg. 314
Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 242-245
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Author(s): Ngim Kenley, Patel Jalpa
Sep/Oct 2021
Pg. 417
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2010
Pg. 426
Rufinamide 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F
Mar/Apr 2021
Pg. 144
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 510
Imatinib 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 59
Voriconazole 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr